+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Banking Outsourcing Market Size, Share & Trends Analysis Report By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type, By Phase, By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 180 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5649339
The global cell banking outsourcing market size is expected to reach USD 35.59 billion by 2030, registering a CAGR of 16.34%, according to this report. Introduction of novel technologies for the collection, testing, and storage of cell lines are expected to boost the cell banking market during the forecast period. Automation in cord blood processing and storage are the key technologies that are expected to affect the growth of the market.

CellTrials.org found that global enrolments of new trials in advanced cell therapy were up almost 30% in the first quarter of 2020. Most of the rise can be associated with cell therapy efforts for treating COVID-19, and over half of those trials for COVID-19 employ umbilical cord MSCs. Hence, the pandemic has created a new market for those companies which are engaged in the manufacturing of MSCs products.

According to a report published by Pharma Intelligence UK Limited, 21 oncological drugs are expected to be launched in 2022. Moreover, these drugs will be used for the treatment of different metabolic disorders which would result in the increased entry of novel biosimilar drugs into the market during the forecast period. For instance, in 2022, Center for Drug Evaluation and Research (CDER), approved 15 new drugs and biological products. Cell lines are highly valuable assets for the production and testing of these biopharmaceuticals. Hence, the increasing number of R&D activities for biosimilar and biologic products is expected to increase demand for the good-quality cell lines, thereby, fueling the demand for banking services.

Monoclonal antibody industry is growing at a rapid pace, owing to the advantages associated with it such as treatment for a wide array of diseases including autoimmune diseases, cancer, and inflammatory diseases. The demand for monoclonal antibodies for the treatment of these diseases is expected to increase during the forecast period, due to the benefits offered by them, which exhibit high efficiency, high specificity, and comparatively lesser side effects.

The increasing number of monoclonal antibody-based viable therapies, as well as the introduction of various new modalities related to their clinical development, are expected to drive the growth of the monoclonal antibodies. A clone with the best properties is chosen and stored in a bank, allowing for the production of monoclonal antibodies to be repeated for a decade. Therefore, the increasing growth of monoclonal antibodies is expected to propel the demand for banking throughout the forecast period.

Human embryonic research poses a moral duty such as respecting the value of human life and preventing suffering. The harvesting of embryonic stem cells violates the duty of respect value for human life as it is a consequence of the destruction of human embryos. In addition, granting of intellectual property rights (IPR) to the product or material used in research and commercialization of such services are the major restraints in cell development. Ethical approval should be obtained before the storage of cell lines and tissues in biorepositories as the technology allows patients identification just from DNA; which may lead to the misuse of tissue for an illegal purpose or for proxy identification of diseases to claim insurance.

Cell Banking Outsourcing Market Report Highlights

  • Master cell banking accounted for the largest market share in 2022, owing to rise in these facilities across the globe. Moreover, master cell banks are useful for the preparation of working cell banks and thus find applicability in various research and development perspectives for gene therapy thereby resulting to segment growth

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Information Procurement
1.3. Information Or Data Analysis
1.4. Market Scope & Segment Definition
1.5. Market Model
1.5.1. Market Study, By Company Market Share
1.5.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological Advancement Involving Cell Banking
3.2.1.2. Patent Expiration Of Blockbuster Biologics
3.2.1.3. Rising Demand For Monoclonal Antibodies
3.2.1.4. Growing R&D Investments In Biotechnology Sector
3.2.1.5. Increasing Prevalence Of Cancer
3.2.2. Market Restraint Analysis
3.2.2.1. Ethical Concern Related To Stem Cell Research
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Cell Banking Outsourcing Market: Type Movement Analysis
4.2. Master Cell Banking
4.2.1. Master Cell Banking Market, 2018 - 2030 (USD Million)
4.3. Working Cell Banking
4.3.1. Working Cell Banking Market, 2018 - 2030 (USD Million)
4.4. Viral Cell Banking
4.4.1. Viral Cell Banking Market, 2018 - 2030 (USD Million)
Chapter 5. Cell-Type Business Analysis
5.1. Cell Banking Outsourcing Market: Cell-Type Movement Analysis
5.2. Stem Cell
5.2.1. Stem Cell Market, 2018 - 2030 (USD Million)
5.2.2. Cord Cell Banking
5.2.2.1. Cord Cell Banking Market, 2018 - 2030 (USD Million)
5.2.3. Embryonic Stem Cell Banking
5.2.3.1. Embryonic Stem Cell Banking Market, 2018 - 2030 (USD Million)
5.2.4. Adult Stem Cell Banking
5.2.4.1. Adult Stem Cell Banking Market, 2018 - 2030 (USD Million)
5.2.5. Dental Stem Cell Banking
5.2.5.1. Dental Stem Cell Banking Market, 2018 - 2030 (USD Million)
5.2.6. IPS Stem Cell Banking
5.2.6.1. IPS Stem Cell Banking Market, 2018 - 2030 (USD Million)
5.3. Non-Stem Cell
5.3.1. Non-Stem Cell Market, 2018 - 2030 (USD Million)
Chapter 6. Phase Business Analysis
6.1. Cell Banking Outsourcing Market: Phase Movement Analysis
6.2. Bank Storage
6.2.1. Bank Storage Market, 2018 - 2030 (USD Million)
6.2.2. Master Cell Bank Preparation
6.2.2.1. Master Cell Bank Preparation Market, 2018 - 2030 (USD Million)
6.2.3. Working Cell Bank Preparation
6.2.3.1. Working Cell Bank Preparation Market, 2018 - 2030 (USD Million)
6.2.4. Cell Storage Stability Testing
6.2.4.1. Cell Storage Stability Testing Market, 2018 - 2030 (USD Million)
6.3. Bank Characterization & Testing
6.3.1. Bank Characterization & Testing Market, 2018 - 2030 (USD Million)
6.3.2. Safety Testing
6.3.2.1. Safety Testing Market, 2018 - 2030 (USD Million)
6.3.2.1.1. Viral Cell Banks
6.3.2.1.1.1. Viral Cell Banks Market, 2018 - 2030 (USD Million)
6.3.2.1.2. Microbial Cell Banks
6.3.2.1.2.1. Microbial Cell Banks Market, 2018 - 2030 (USD Million)
6.3.3. Gene Expression Testing
6.3.3.1. Gene Expression Testing Market, 2018 - 2030 (USD Million)
6.3.4. Karyology Testing
6.3.4.1. Karyology Testing Market, 2018 - 2030 (USD Million)
6.3.5. Gene Sequencing Testing
6.3.5.1. Gene Sequencing Testing Market, 2018 - 2030 (USD Million)
6.4. Bank Preparation
6.4.1. Bank Preparation Market, 2018 - 2030 (USD Million)
6.4.2. Master Cell Bank Preparation
6.4.2.1. Master Cell Bank Preparation Market, 2018 - 2030 (USD Million)
6.4.3. Working Cell Bank Preparation
6.4.3.1. Working Cell Bank Preparation Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Cell Banking Outsourcing Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. U.S. Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Competitive Scenario
7.2.4.3. Canada Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. UK Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Germany Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. France Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Italy Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Spain Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Denmark Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Sweden Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Competitive Scenario
7.3.10.3. Norway Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Japan Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. China Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. India Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Australia Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Thailand Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. South Korea Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Brazil Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Mexico Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Argentina Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. South Africa Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Saudi Arabia Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. UAE Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Kuwait Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Bio Outsource (Sartorious)
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. BSL Bioservice
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Cryo-Cell International, Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Charles River Laboratories
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. LifeCell
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. GBI
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Lonza
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. SGS Société Générale de Surveillance SA
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Perfectus Biomed Limited
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
List of Tables
Table 1: List of abbreviations
Table 2: Global Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 3: Global Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 4: Global Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 5: Global Cell banking outsourcing market, by region, 2018-2030 (USD Million)
Table 6: North America Cell banking outsourcing market, by country, 2018-2030 (USD Million)
Table 7: North America Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 8: North America Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 9: North America Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 10: U.S. Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 11: U.S. Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 12: U.S. Cell banking outsourcing Market, by phase, 2018-2030 (USD Million)
Table 13: Canada Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 14: Canada Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 15: Canada Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 16: Europe Cell banking outsourcing market, by country, 2018-2030 (USD Million)
Table 17: Europe Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 18: Europe Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 19: Europe Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 20: UK Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 21: UK Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 22: UK Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 23: Germany Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 24: Germany Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 25: Germany Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 26: France Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 27: France Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 28: France Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 29: Italy Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 30: Italy Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 31: Italy Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 32: Spain Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 33: Spain Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 34: Spain Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 35: Denmark Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 36: Denmark Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 37: Denmark Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 38: Sweden Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 39: Sweden Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 40: Sweden Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 41: Norway Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 42: Norway Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 43: Norway Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 44: Asia Pacific Cell banking outsourcing market, by country, 2018-2030 (USD Million)
Table 45: Asia Pacific Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 46: Asia Pacific Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 47: Asia Pacific Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 48: Japan Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 49: Japan Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 50: Japan Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 51: China Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 52: China Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 53: China Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 54: India Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 55: India Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 56: India Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 57: Australia Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 58: Australia Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 59: Australia Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 60: Thailand Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 61: Thailand Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 62: Thailand Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 63: South Korea Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 64: South Korea Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 65: South Korea Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 66: Latin America Cell banking outsourcing market, by country, 2018-2030 (USD Million)
Table 67: Latin America Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 68: Latin America Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 69: Latin America Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 70: Brazil Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 71: Brazil Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 72: Brazil Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 73: Mexico Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 74: Mexico Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 75: Mexico Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 76: Argentina Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 77: Argentina Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 78: Argentina Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 79: Middle East & Africa Cell banking outsourcing market, by country, 2018-2030 (USD Million)
Table 80: Middle East & Africa Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 81: Middle East & Africa Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 82: Middle East & Africa Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 83: South Africa Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 84: South Africa Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 85: South Africa Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 86: Saudi Arabia Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 87: Saudi Arabia Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 88: Saudi Arabia Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 89: UAE Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 90: UAE Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 91: UAE Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
Table 92: Kuwait Cell banking outsourcing market, by type, 2018-2030 (USD Million)
Table 93: Kuwait Cell banking outsourcing market, by cell type, 2018-2030 (USD Million)
Table 94: Kuwait Cell banking outsourcing market, by phase, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information procurement
Fig. 3: Primary research pattern
Fig. 4: Market research approaches
Fig. 5: Value chain-based sizing & forecasting
Fig. 6: Market formulation & validation
Fig. 7: single-cell omics market segmentation
Fig. 8: Market snapshot, 2022
Fig. 9: Market trends & outlook
Fig. 10: Market driver relevance analysis (current & future impact)
Fig. 11: Market restraint relevance analysis (current & future impact)
Fig. 12: PESTEL analysis
Fig. 13: Porter’s five forces analysis
Fig. 14: Global Cell banking outsourcing market: type movement analysis
Fig. 15: Global Cell banking outsourcing market, for master cell banking, 2018-2030 (USD Million)
Fig. 16: Global Cell banking outsourcing market, for working cell banking, 2018-2030 (USD Million)
Fig. 17: Global Cell banking outsourcing market, for viral cell banking, 2018-2030 (USD Million)
Fig. 18: Global Cell banking outsourcing market: Cell type movement analysis
Fig. 19: Global Cell banking outsourcing market, for stem cells, 2018-2030 (USD Million)
Fig. 20: Global cord cell banking market, 2018-2030 (USD Million)
Fig. 21: Global embryonic stem cell market, 2018-2030 (USD Million)
Fig. 22: Global adult stem cell banking market, 2018-2030 (USD Million)
Fig. 23: Global dental stem cell banking market, 2018-2030 (USD Million)
Fig. 24: Global IPS stem cell banking market, 2018-2030 (USD Million)
Fig. 25: Global Cell banking outsourcing market: Phase movement analysis
Fig. 26: Global bank storage market, 2018-2030 (USD Million)
Fig. 27: Global master cell bank prep market, 2018-2030 (USD Million)
Fig. 28: Global working cell bank prep market, 2018-2030 (USD Million)
Fig. 29: Global cell storage stability testing market, 2018-2030 (USD Million)
Fig. 30: Global bank characterization & testing market, 2018-2030 (USD Million)
Fig. 31: Global safety testing market, 2018-2030 (USD Million)
Fig. 32: Global viral cell banks market, 2018-2030 (USD Million)
Fig. 33: Global gene expression testing market, 2018-2030 (USD Million)
Fig. 34: Global karyology testing market, 2018-2030 (USD Million)
Fig. 35: Global gene sequencing testing market, 2018-2030 (USD Million)
Fig. 36: Global bank preparation market, 2018-2030 (USD Million)
Fig. 37: Global master cell bank prep market, 2018-2030 (USD Million)
Fig. 38: Global working cell bank prep market, 2018-2030 (USD Million)
Fig. 39: Regional marketplace: Key takeaways
Fig. 40: Regional outlook, 2022 & 2030
Fig. 41: Global Cell banking outsourcing market: Region movement analysis
Fig. 42: North America Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 43: U.S. Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 44: Canada Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 45: Europe Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 46: Germany Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 47: UK Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 48: France Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 49: Italy Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 50: Spain Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 51: Denmark Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 52: Sweden Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 53: Norway Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 54: Asia Pacific Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 55: Japan Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 56: China Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 57: India Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 58: Australia Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 59: South Korea Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 60: Thailand Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 61: Latin America Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 62: Brazil Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 63: Mexico Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 64: Argentina Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 65: Middle East and Africa Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 66: South Africa Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 67: Saudi Arabia Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 68: UAE Cell banking outsourcing market, 2018-2030 (USD Million)
Fig. 69: Kuwait Cell banking outsourcing market, 2018-2030 (USD Million)

Companies Mentioned

  • Bio Outsource (Sartorious)
  • BSL Bioservice
  • Cryo-Cell International, Inc.
  • Charles River Laboratories
  • LifeCell
  • GBI
  • Lonza
  • SGS Société Générale de Surveillance SA
  • Perfectus Biomed Limited

Methodology

Loading
LOADING...

Table Information